Calcitriol and 20(S)-protopanaxadiol synergistically inhibit growth and induce apoptosis in human prostate cancer

被引:24
|
作者
Ben-Eltriki, Mohamed [1 ,2 ]
Deb, Subrata [4 ]
Adomat, Hans [1 ]
Guns, Emma S. Tomlinson [1 ,3 ]
机构
[1] Vancouver Gen Hosp, Vancouver Prostate Ctr, 2660 Oak St, Vancouver, BC V6H 3Z6, Canada
[2] Univ British Columbia, Fac Med, Dept Expt Med, Vancouver, BC, Canada
[3] Univ British Columbia, Fac Med, Dept Urol Sci, Vancouver, BC, Canada
[4] Roosevelt Univ, Coll Pharm, Dept Biopharmaceut Sci, Schaumburg, IL USA
关键词
20(S)-protopanaxadiol ginsenoside; Prevention; Prostate cancer; Synergism; Pharmacodynamics; Vitamin D receptor; ACTIVITY IN-VITRO; VITAMIN-D; 1-ALPHA; 25-DIHYDROXYVITAMIN D-3; ANTITUMOR-ACTIVITY; NATURAL-PRODUCT; HUMAN LIVER; ANDROGEN; ANTICANCER; MECHANISMS; CELLS;
D O I
10.1016/j.jsbmb.2015.12.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The potential cancer preventive roles of calcitriol, the dihydroxylated metabolite of Vitamin D-3, as well as 20(S)-protopanaxadiol (aPPD), the aglycone of the protopanaxadiol family of ginsenosides, have gained much attention in recent years for the prevention/treatment of prostate cancer (PCa). In the present study, we evaluated the anticancer and chemosensitization effects of calcitriol at clinically relevant concentrations and aPPD, either alone or in combination, in two well-characterized human PCa cell lines: androgen-sensitive non-metastatic LNCaP cells and androgen-independent metastatic C4-2 cells. The effects of the treatments on PCa cell viability and proliferation rates were evaluated by MTS and Brdu assays, respectively. Combination Indices (CI) and Dose Reduction Indices (DRI) were estimated to assess synergistic anticancer activity using Calcusyn software (Biosoft, Cambridge, UK). Then, we determined the potential Pharmacodynamic interaction mechanisms as follows: The protein expression levels of the genes those are known to control cell cycle (cyclin D1 and cdk2); apoptosis (Bcl-2, Bax, and Capspases 3), androgen receptor and Vitamin D receptors were examined upon combinational treatment. The cell viability assay data show that addition of 10 nM calcitriol to aPPD significantly lowered its IC50 values from the range of 41-53 mu M to 13-23 mu M, in LNCaP and C4-2 prostate cancer cells. The cell proliferation rate was significantly lower for combination treatments compared to the cells treated with aPPD alone. Similarly, Western blot results indicate that aPPD significantly upregulated Vitamin D receptor (VDR) expression, while calcitriol further enhanced the ability of aPPD to induce pro-apoptotic BAX, increased cleaved caspase-3 and downregulate cdk(2) protein levels. Thus, the pharmacodynamic interaction between aPPD and calcitriol in impacting growth inhibition and apoptosis appears to be synergistic in nature. In conclusion, calcitriol sensitizes PCa cells to aPPD-mediated anticancer effects by enhancing its ability to induce apoptosis and reduce cell proliferation, and this synergism may limit calcitriol toxicity by facilitating the use of lower calcitriol doses. The associated increase in VDR expression and calcitriol half-life may be mechanistically associated with this sensitization effect. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:207 / 219
页数:13
相关论文
共 50 条
  • [1] Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines
    Lim, JTE
    Piazza, GA
    Han, EKH
    Delohery, TM
    Li, H
    Finn, TS
    Buttyan, R
    Yamamoto, H
    Sperl, GJ
    Brendel, K
    Gross, PH
    Pamukcu, R
    Weinstein, IB
    [J]. BIOCHEMICAL PHARMACOLOGY, 1999, 58 (07) : 1097 - 1107
  • [2] Goserelin loaded nanoparticles inhibit growth and induce apoptosis in human prostate cancer cell lines
    Priti Tomar
    Neeti Jain
    G. S. Agarwal
    V. K. Dixit
    [J]. Drug Delivery and Translational Research, 2012, 2 : 265 - 271
  • [3] Silibinin synergizes with mitoxantrone to inhibit cell growth and induce apoptosis in human prostate cancer cells
    Flaig, Thomas W.
    Sui, Lih-Jen
    Harrison, Gail
    Agarwal, Rajesh
    Glode, Leonard Michael
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2007, 120 (09) : 2028 - 2033
  • [4] Goserelin loaded nanoparticles inhibit growth and induce apoptosis in human prostate cancer cell lines
    Tomar, Priti
    Jain, Neeti
    Agarwal, G. S.
    Dixit, V. K.
    [J]. DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2012, 2 (04) : 265 - 271
  • [5] A novel ginsenoside 20(S)-protopanaxadiol inhibits growth of castration-resistant human prostate cancer
    Ben-Eltriki, M.
    Hassona, M.
    Meckling, G.
    Fazli, L.
    Deb, S.
    Guns, E. S. Tomlinson
    [J]. PLANTA MEDICA, 2016, 82
  • [6] 20(S)-Protopanaxadiol Inhibition of Progression and Growth of Castration-Resistant Prostate Cancer
    Cao, Bo
    Qi, Yanfeng
    Yang, Yan
    Liu, Xichun
    Xu, Duo
    Guo, Wei
    Zhan, Yang
    Xiong, Zhenggang
    Zhang, Allen
    Wang, Alun R.
    Fu, Xueqi
    Zhang, Haitao
    Zhao, Lijing
    Gu, Jingkai
    Dong, Yan
    [J]. PLOS ONE, 2014, 9 (11):
  • [7] Epidermal growth factor and calcitriol synergistically induce osteoblast maturation
    Yarram, SJ
    Tasman, C
    Gidley, J
    Clare, M
    Sandy, JR
    Mansell, JP
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2004, 220 (1-2) : 9 - 20
  • [8] Antisense protein kinase a RIα acts synergistically with hydroxycamptothecin to inhibit growth and induce apoptosis in human cancer cells:: Molecular basis for combinatorial therapy
    Cho, YS
    Cho-Chung, YS
    [J]. CLINICAL CANCER RESEARCH, 2003, 9 (03) : 1171 - 1178
  • [9] T-Oligos Inhibit Growth and Induce Apoptosis in Human Ovarian Cancer Cells
    Sarkar, Sibaji
    Faller, Douglas V.
    [J]. OLIGONUCLEOTIDES, 2011, 21 (01) : 47 - 53